Paper39265498
Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway.
Liu J and 7 others. Redox Biol, 2024. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway. Papers, record 39265498. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39265498
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| NF-E2-Related Factor 2 | Major topic |
| Blood-Brain Barrier | Major topic |
| HMGB1 Protein | Major topic |
| Ferroptosis | Major topic |
| Endothelial Cells | Major topic |
| Lipocalin-2 | Major topic |
| Humans | |
| Animals | |
| Male | |
| Rats | |
| Female | |
| Signal Transduction | |
| Aged | |
| Middle Aged | |
| Thrombolytic Therapy | |
| Ischemic Stroke | |
| Heme Oxygenase-1 |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984912 | Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation. | Oncol Res | 2026 | https://conductscience.org/library/papers/42984912 | PubMed |
| 42835684 | Targeting lipocalin-2 in atherosclerosis: biological functions, pathogenic mechanisms, and therapeutic potential. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42835684 | PubMed |
| 42793383 | Notoginsenoside R1 Attenuates Oxidative Damage After Intracerebral Hemorrhage by Inhibiting LCN2 and Promoting HO-1 in Astrocytes. | Brain Sci | 2026 | https://conductscience.org/library/papers/42793383 | PubMed |
| 42769396 | ACT001 suppresses ox-LDL-mediated macrophage ferroptosis via activating the NRF2 pathway: An in vitro mechanistic study relevant to atherosclerosis. | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42769396 | PubMed |
| 42736277 | Transcriptomic analysis reveals that neural stem cell-derived exosomes regulate the HMGB1/TLR2 signaling axis to promote astrocytic differentiation and mitochondrial biogenesis in the repair of radiation-induced blood-brain barrier damage. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42736277 | PubMed |
| 42706694 | Lipocalin 13 Mitigates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Inhibiting the ADRB2/ERK Signalling Pathway. | Liver Int | 2026 | https://conductscience.org/library/papers/42706694 | PubMed |
| 42609639 | Lcn2 Promotes Ferroptosis in Intracerebral Hemorrhage by Targeting Keap1 Tyr572 and Restricting Nrf2 Activation. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42609639 | PubMed |
| 42608542 | Astrocytic LCN2 mediates pathological crosstalk with neurons to promote neuronal loss in sepsis-associated encephalopathy. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/42608542 | PubMed |
| 42454488 | The bone-cerebrovascular axis: effects of bone aging on neurovascular dysfunction and neurodegeneration. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42454488 | PubMed |
| 42363270 | Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42363270 | PubMed |
| 42327731 | Endothelial ferroptosis in blood-brain barrier dysfunction and neuroinflammation: mechanisms and immune-vascular crosstalk. | Front Immunol | 2026 | https://conductscience.org/library/papers/42327731 | PubMed |
| 42268517 | Ischemic Stroke Induces Ferroptosis and Neuroinflammation via Activation of the Microglial Tbp-Lpl Transcriptional Axis. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42268517 | PubMed |
| 42232166 | Decoding ferroptosis in intracerebral hemorrhage: multidimensional monitoring and integrative perspectives beyond single biomarkers. | Front Neurol | 2026 | https://conductscience.org/library/papers/42232166 | PubMed |
| 42207425 | Interference with HMGB1 Inhibits Neuronal Ferroptosis Following Spinal Cord Injury through Targeting ACSL4. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42207425 | PubMed |
| 42178429 | Artesunate overcomes oxaliplatin resistance in colorectal cancer by inducing ferroptosis through inhibition of the CDK5/Nrf2/GPX4 pathway. | Apoptosis | 2026 | https://conductscience.org/library/papers/42178429 | PubMed |
| 42169036 | Syringaresinol alleviates acetaminophen-induced hepatocyte ferroptosis through the Nrf2/HO-1 pathway by targeting Caveolin-1. | Chin Med | 2026 | https://conductscience.org/library/papers/42169036 | PubMed |
| 42112745 | Colchicine alleviates severe acute pancreatitis in rats by inhibiting acinar cell ferroptosis via LCN2/MAPK/ERK signaling axis. | Eur J Histochem | 2026 | https://conductscience.org/library/papers/42112745 | PubMed |
| 42088773 | Melatonin promotes skin flap survival by inhibiting ferroptosis via activation of the Nrf2/HO-1 pathway. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42088773 | PubMed |
| 42072145 | Ferroptosis in Vascular Diseases: A Mechanistic and Immunological Perspective on Therapeutic Targeting. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072145 | PubMed |
| 42057848 | APMCG-1: a mountain-cultivated ginseng-derived glycopeptide alleviates cerebral ischemic injury by resisting oxidative stress, ferroptosis and inflammation via the Nrf2 signaling pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42057848 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| LCN2 | 3934 | PubTator's text mining | https://conductscience.org/library/genes/3934 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| XIAP | 331 | PubTator's text mining | https://conductscience.org/library/genes/331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39265498
GET https://conductscience.org/api/papers/v1/39265498/cited_by?page=2